Built with over 1,000 NVIDIA Blackwell Ultra GPUs, LillyPod is now online to power scientific research and supercharge the future of medicine.
Lilly has launched the most powerful AI factory wholly owned and operated by a pharmaceutical company to help its teams make meaningful medical advancements faster, more accurately and at unprecedented scale. Dubbed LillyPod, it’s the world’s first NVIDIA DGX SuperPOD with DGX B300 systems.
Powered by a DGX SuperPOD with 1,016 NVIDIA Blackwell Ultra GPUs, Lilly’s AI factory delivers more than 9,000 petaflops of AI performance. It was assembled in just four months.
“It’s a big day for us with the supercomputer coming on board, but it’s a day 150 years in the making,” said Diogo Rau, Executive Vice President and Chief Information and Digital Officer at Lilly. “LillyPod is a powerful symbol of who we are and why we do this work: to make life better for people around the world. We are, right here, right now, at the right moment to advance biology in a way that has just never been done before.”
Computational power that once required seven million Cray supercomputers now fits inside a single NVIDIA GPU — and LillyPod contains more than 1,000 of them. This infrastructure enables Lilly’s genomics team to harness 700 terabytes of data using over 290 terabytes of high-bandwidth GPU memory.
“Computation is at the heart of biology and it is at the heart of science,” said Thomas Fuchs, Senior Vice President and Chief AI Officer at Lilly. “Being able to compute at scale is not something optional for a company like ours, it is absolutely necessary. So we are building the computational future of medicine and you see that in all areas along the pharmaceutical value chain.”
Lilly’s AI factory is set to support the large-scale training of protein diffusion models, small-molecule graph neural network models and genomics foundation models.
NVIDIA’s full-stack AI factory architecture offered with NVIDIA DGX SuperPOD – including accelerated computing, NVIDIA Spectrum-X Ethernet networking and optimized AI software – provides a secure, scalable platform for the highly regulated workflows of healthcare and life sciences.
NVIDIA Mission Control software allows Lilly to manage its DGX SuperPOD, orchestrate workloads, monitor performance and automate AI operations securely and efficiently.
The supercomputer’s nearly 5,000 connections are built with more than 1,000 pounds of fiber cables. Lilly aims for its new AI supercomputing infrastructure to run on 100% renewable electricity by 2030, using efficient liquid cooling and minimal incremental energy impact.
For more news like this, click here.